BIOLINERX
Careers | Contact Us
search

Press Releases
June 15, 2015
- BL-8040’s rapid stem-cell mobilization supports stand-alone one-day treatment for stem-cell collection -
- Graft derived from BL-8040 treatment shows unique cell composition -
May 11, 2015
Management to hold a conference call at 10:00 a.m. EDT
May 4, 2015

BL-8040 remains safe and well tolerated at highest dose; continues to induce robust mobilization and leukemia cell death

Top-line results expected Q4 2015

March 25, 2015
BL-8040 Phase 1 study met all safety and efficacy endpoints
High stem-cell yield supports novel single-day collection procedure

121-130  Out of  309 Previous
 1   2   3   4   5   6   7   8   9   10   11   12   13   14   15 
 16   17   18   19   20   21   22   23   24   25   26   27   28   29 
 30   31 
Next